EQUUS TOTAL RETURN INC (EQS) Fundamental Analysis & Valuation

NYSE:EQS • US2947661003

Current stock price

1.66 USD
-0.1 (-5.95%)
Last:

This EQS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. EQS Profitability Analysis

1.1 Basic Checks

  • In the past year EQS has reported negative net income.
  • In the past year EQS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: EQS reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: EQS reported negative operating cash flow in multiple years.
EQS Yearly Net Income VS EBIT VS OCF VS FCFEQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

  • EQS has a Return On Assets of -45.35%. This is amonst the worse of the industry: EQS underperforms 93.33% of its industry peers.
  • Looking at the Return On Equity, with a value of -49.35%, EQS is doing worse than 85.42% of the companies in the same industry.
Industry RankSector Rank
ROA -45.35%
ROE -49.35%
ROIC N/A
ROA(3y)-17.4%
ROA(5y)-13.32%
ROE(3y)-13.15%
ROE(5y)-13.74%
ROIC(3y)N/A
ROIC(5y)N/A
EQS Yearly ROA, ROE, ROICEQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • EQS has a Gross Margin of 88.97%. This is amongst the best in the industry. EQS outperforms 94.17% of its industry peers.
  • In the last couple of years the Gross Margin of EQS has declined.
  • EQS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-1.74%
EQS Yearly Profit, Operating, Gross MarginsEQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. EQS Health Analysis

2.1 Basic Checks

  • EQS has about the same amout of shares outstanding than it did 1 year ago.
  • EQS has more shares outstanding than it did 5 years ago.
  • EQS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EQS Yearly Shares OutstandingEQS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
EQS Yearly Total Debt VS Total AssetsEQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 2.94 indicates that EQS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • EQS has a Altman-Z score of 2.94. This is in the better half of the industry: EQS outperforms 76.25% of its industry peers.
  • EQS has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
  • EQS has a Debt to FCF ratio of 0.03. This is amongst the best in the industry. EQS outperforms 93.33% of its industry peers.
  • EQS has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • EQS's Debt to Equity ratio of 0.05 is amongst the best of the industry. EQS outperforms 82.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.03
Altman-Z 2.94
ROIC/WACCN/A
WACCN/A
EQS Yearly LT Debt VS Equity VS FCFEQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

  • EQS has a Current Ratio of 1.06. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
  • EQS has a Current ratio of 1.06. This is comparable to the rest of the industry: EQS outperforms 46.67% of its industry peers.
  • A Quick Ratio of 1.06 indicates that EQS should not have too much problems paying its short term obligations.
  • The Quick ratio of EQS (1.06) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
EQS Yearly Current Assets VS Current LiabilitesEQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EQS Growth Analysis

3.1 Past

  • The earnings per share for EQS have decreased strongly by -271.83% in the last year.
  • The Revenue has grown by 62.10% in the past year. This is a very strong growth!
  • The Revenue has been growing by 29.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-271.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.45%
Revenue 1Y (TTM)62.1%
Revenue growth 3YN/A
Revenue growth 5Y29.4%
Sales Q2Q%9.09%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQS Yearly Revenue VS EstimatesEQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2023 2024 200K 400K 600K 800K 1M

More info and screens

Find the best growth stocksShow best growing peers

2

4. EQS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EQS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EQS Price Earnings VS Forward Price EarningsEQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • EQS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EQS is cheaper than 98.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.47
EV/EBITDA N/A
EQS Per share dataEQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EQS Dividend Analysis

5.1 Amount

  • No dividends for EQS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EQS Fundamentals: All Metrics, Ratios and Statistics

EQUUS TOTAL RETURN INC

NYSE:EQS (3/20/2026, 8:04:00 PM)

1.66

-0.1 (-5.95%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-12
Earnings (Next)04-08
Inst Owners1.07%
Inst Owner Change0.61%
Ins Owners33.7%
Ins Owner Change0%
Market Cap23.19M
Revenue(TTM)1.36M
Net Income(TTM)-16.78M
Analysts0
Price TargetN/A
Short Float %0.23%
Short Ratio2.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.05
P/FCF 0.47
P/OCF 0.47
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.57
FCFY214.79%
OCF(TTM)3.57
OCFY214.79%
SpS0.1
BVpS2.44
TBVpS2.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.35%
ROE -49.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.97%
FCFM 3662.5%
ROA(3y)-17.4%
ROA(5y)-13.32%
ROE(3y)-13.15%
ROE(5y)-13.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-1.74%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.03
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 2.94
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-271.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)62.1%
Revenue growth 3YN/A
Revenue growth 5Y29.4%
Sales Q2Q%9.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y454.77%
FCF growth 3Y21.64%
FCF growth 5YN/A
OCF growth 1Y454.77%
OCF growth 3Y21.64%
OCF growth 5YN/A

EQUUS TOTAL RETURN INC / EQS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EQUUS TOTAL RETURN INC (EQS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EQS.


What is the valuation status of EQUUS TOTAL RETURN INC (EQS) stock?

ChartMill assigns a valuation rating of 2 / 10 to EQUUS TOTAL RETURN INC (EQS). This can be considered as Overvalued.


What is the profitability of EQS stock?

EQUUS TOTAL RETURN INC (EQS) has a profitability rating of 2 / 10.